Enjoy complimentary customisation on priority with our Enterprise License!
The enzyme-linked immunosorbent assay (ELISA) market size is forecast to increase by USD 843.9 million at a CAGR of 16.82% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. One major factor is the increasing prevalence of chronic diseases and autoimmune disorders, leading to a greater demand for diagnostic tests in hospitals and research laboratories. ELISA's versatility, with both colorimetric and fluorescent detection methods, makes it an ideal choice for diagnosing conditions such as diabetes and prediabetes. Additionally, the trend towards multiplex assays and personalized medicine is driving market growth, as ELISA can be used to detect multiple biomarkers in a single test. However, challenges remain, including the lack of accessibility and affordability of diagnostic tests in developing countries.
_Market_size_abstract_2023_v1.jpg.webp?v4.1.20)
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.